What is neuropacsTM?

neuropacs™ is a comprehensive suite of AI-powered, imaging-enabled software built specifically for neurodegenerative diseases to:

  • Detect disease 
  • Quantify neurodegeneration
  • Analyze clinical diagnostics
  • Improve clinical trial outcomes

Measure

Quantitative progression markers for efficacy assessment

Stratify

Advanced diagnostic tools for precise patient stratification

Optimize

Precision inputs bolster clinical endpoint achievement

Comprehensive Toolset

Delivered via secure cloud-based workflow

Unmatched Accuracy

Up to 98% precision in distinguishing PD from MSAp and PSP

Whether supporting clinical decision-making or powering trial success, neuropacs™ provides exclusive methodologies, actionable insights, and a seamless integration into existing imaging workflows.

98%

Up to 98% accuracy

21 sites

involved in most recent clinical trial

15+

Years of data collected

1000+

Unique datasets analyzed

Exclusive, Patented Technology

neuropacs™ leverages proprietary, patent-protected techniques that combine:

  • AI-driven diagnostics trained on
    harmonized multi-site data
  • Exclusive Patent: US 10,758,170 for Parkinsonism
  • Patent pending for Dementia and Alzheimer’s
  • Free-Water Imaging (FWI): A powerful diffusion MRI method that enhances early disease detection
  • FDA DeNovo device clearance: anticipated in 2025

Our Patents

Patents and patent-pending filings cover multiple neurodegenerative indications, including: 

•Alzheimer’s Disease

•Parkinson’s Disease

•Multiple System Atrophy (MSA)

•Progressive Supranuclear Palsy (PSP)

•Dementia with Lewy Bodies

•Amyotrophic Lateral Sclerosis (ALS)

•Motor Neuron Disease (MND)

•Corticobasal Degeneration

•Huntington’s Disease Multiple Sclerosis (MS)

Evidence and Expertise

neuropacs™ is the result of decades of research led by world-class clinicians and neuroscientists from:

•University of Florida

•UF Health Norman Fixel Institute for Neurological Diseases

Validated across thousands of MRI scans and multiple clinical trials, neuropacs™ delivers:

•Peer-reviewed results

•Academic rigor

•Real-world applicability

•FDA enabled

•Most sensitive platform available

neuropacsTM agent

This video explains how our diagnostic software can be seamlessly integrated with your existing PACS system using our state-of-the-art secure and scalable cloud solution.

Ready to improve your outcomes using our precision AI platform?

Our dedicated team can help you determine which neuropacs™ solution best fits your clinical or research needs.

Get Started
Learn More